SCHEMBL6377752

SCHEMBL6377752

C[C@@H]1CCC[C@@](CO)(CC(=O)O)C1

nearest known ligand 0.83

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.83
USP2 O75604 1/20 0.42
ALDH1A1 P00352 1/20 0.42
LMNA P02545 1/20 0.42
TSHR P16473 1/20 0.42
BLM P54132 1/20 0.42
CACNA2D1 P54289 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
HSD11B1 P28845 1/20 0.35
KMT2A Q03164 2/20 0.34
KDM4E B2RXH2 1/20 0.33
PKM P14618 1/20 0.33
CYP2C19 P33261 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6377748 1.00 CYP1A2 (0.83) CYP1A2USP2ALDH1A1LMNATSHR
SCHEMBL2870375 0.91 CYP1A2 (1.00) CYP1A2USP2ALDH1A1LMNATSHR
SCHEMBL32690126 0.91 CYP1A2 (1.00) CYP1A2USP2ALDH1A1LMNATSHR
SCHEMBL7416439 0.85 CYP1A2 (0.81) CYP1A2USP2ALDH1A1LMNATSHR
SCHEMBL27726 0.85 CYP1A2 (0.81) CYP1A2USP2ALDH1A1LMNATSHR
SCHEMBL3866042 0.85 CYP1A2 (0.81) CYP1A2USP2ALDH1A1LMNATSHR
SCHEMBL2338208 0.85 CYP1A2 (0.81) CYP1A2USP2ALDH1A1LMNATSHR
SCHEMBL6377387 0.85 CYP1A2 (0.81) CYP1A2USP2ALDH1A1LMNATSHR
Hydrochloric Acid SCHEMBL6376591 0.83 CYP1A2 (0.78) CYP1A2USP2ALDH1A1LMNATSHR
Hydrochloric Acid SCHEMBL27548750 0.83 CYP1A2 (0.78) CYP1A2USP2ALDH1A1LMNATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1157000-B1 BRANCHED CHAIN AMINO ACID-DEPENDENT AMINOTRANSFERASE INHIBITORS AND THEIR USE IN THE TREATMENT OF DIABETIC RETINOPATHY WARNER LAMBERT CO (US) 2005-11-02 EP claimed
EP-1157000-B1 BRANCHED CHAIN AMINO ACID-DEPENDENT AMINOTRANSFERASE INHIBITORS AND THEIR USE IN THE TREATMENT OF DIABETIC RETINOPATHY WARNER LAMBERT CO (US) 2005-11-02 EP disclosed